Page last updated: 2024-08-21

2-tert-butylhydroquinone and Degenerative Diseases, Central Nervous System

2-tert-butylhydroquinone has been researched along with Degenerative Diseases, Central Nervous System in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cha, Y; Kim, J; Kim, S; Koh, K1
Huang, B; Li, H; Lin, W; Wang, Z; Wu, S; Zhang, C1

Other Studies

2 other study(ies) available for 2-tert-butylhydroquinone and Degenerative Diseases, Central Nervous System

ArticleYear
tBHQ inhibits LPS-induced microglial activation via Nrf2-mediated suppression of p38 phosphorylation.
    Biochemical and biophysical research communications, 2009, Mar-13, Volume: 380, Issue:3

    Topics: Animals; Antioxidants; Cell Death; Cell Line; Culture Media, Conditioned; Cytoprotection; Hydroquinones; Lipopolysaccharides; Mice; Microglia; Neurodegenerative Diseases; Neurons; NF-E2-Related Factor 2; p38 Mitogen-Activated Protein Kinases; Phosphorylation

2009
Neuroprotective effects of tert-butylhydroquinone on paraquat-induced dopaminergic cell degeneration in C57BL/6 mice and in PC12 cells.
    Archives of toxicology, 2012, Volume: 86, Issue:11

    Topics: Animals; Apoptosis; Base Sequence; Dopaminergic Neurons; Gene Expression Regulation, Enzymologic; Heme Oxygenase-1; Hydroquinones; Male; Membrane Proteins; Mice; Mice, Inbred C57BL; Molecular Sequence Data; Motor Activity; Neurodegenerative Diseases; Neuroprotective Agents; NF-E2-Related Factor 2; Paraquat; PC12 Cells; Rats; Substantia Nigra; Tyrosine 3-Monooxygenase

2012